CombineHealth vs GenHealth.ai
Two RCM Automation Platforms vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| CombineHealth | GenHealth.ai | |
|---|---|---|
| Pricing model | Per-transaction / per-chart · Priced per chart or claim worked | Usage-based · Per workflow, plus actions run each month |
| Speed to go live | Sidecar agents on existing EHR, weeks | Browser agents, no EHR integration project |
| Automation model | Autonomous agents · Named agents with human escalation | Autonomous agents · AI agents execute RCM workflows |
| Built for | Mid-size groups, Billing companies | Small practices, Mid-size groups, Payers |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 4 yrs (est. 2022) | 3 yrs (est. 2023) |
| Financial backing | Pre-seed (Y Combinator W23) | $13M · Seed |
| Named customers | 5 named | 5 named |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | 3 listed | EHR-agnostic |
| Third-party validation | None found | KLAS / analyst cited |
Bottom line
- Pick CombineHealth if you want an early-stage, aggressively priced AI agent workforce across coding, billing, and denials and can accept startup vendor risk.
- Pick GenHealth.ai if you want prior auth, eligibility, claims automation, or other custom work done by autonomous agents in your existing systems within weeks, without an integration project.
CombineHealth
Named AI agents that work the revenue cycle end to end
- Founded
- 2022
- HQ
- San Francisco, CA
- Stage
- Pre-seed (Y Combinator W23)
- Raised
- $500K
What it does
- Amy codes encounters with rationale in 2-4 minutes
- Mark preps claim-ready charges and posts payments
- Adam works denials, payer portals, and IVR calls
- Rachel drafts and files appeals
- Taylor surfaces revenue cycle analytics and leakage
- Human-in-the-loop escalation with explainable decisions
Where it's strong
- Covers front, mid, and back office with one agent framework instead of point tools.
- Publishes concrete accuracy claims (97% coding accuracy, 20% denial reduction on 10,000+ claims).
- Small YC-backed team moves fast and prices aggressively against legacy RCM vendors.
What buyers should weigh
- Only $500K disclosed funding and a small team, so vendor viability is a real diligence item.
- Customer list skews to mid-size groups and ER networks, not large health systems.
- Agent autonomy claims need validation in your specialty and payer mix before scaling.
Named customers
Union Health · McFarland Clinic · SignatureCare ER · Brault · Medcor
Integrations
GenHealth.ai
An agentic OS for healthcare administration
- Founded
- 2023
- HQ
- San Francisco, CA
- Stage
- Seed
- Raised
- $13M
What it does
- Reads faxed and emailed orders and enters intake data into the EMR
- Verifies eligibility and benefits before orders move forward
- Drafts and submits prior authorizations matched to payer policy
- Checks clinical documentation against payer criteria and flags gaps
- Files claims and works denials and collections
- Automates resupply programs and utilization management review
Where it's strong
- Publishes customer results with real numbers: Piedmont Medical Solutions reported a 34.2% increase in paid-to-date collections, and Guidehealth reported $1.2M in annual savings.
- Multimodal by design: direct integrations with Epic, eClinicalWorks, athenahealth, and Brightree, plus browser agents that log in and work any portal, fax queue, or phone tree without an API.
- Founded by the team behind interoperability company 1upHealth, with backing from Craft Ventures and Obvious Ventures and advisors including Aneesh Chopra and Don Rucker.
- Named in multiple Gartner Hype Cycle reports, including Healthcare Data, Analytics and AI (2024), Generative AI (2024), and US Healthcare Payers (2025), rare analyst visibility for a seed-stage company.
What buyers should weigh
- Founded in 2023 and still at seed stage, so it is a young vendor compared with established RCM and prior auth incumbents.
- Public case studies concentrate in DME/HME and MSO utilization management; evidence in other care settings is thinner.
- No new funding round has been publicly announced since the July 2023 seed, so buyers should ask about company scale and support capacity.
Named customers
Piedmont Medical Solutions · Guidehealth · MedExpress · Soundview Medical · Spectrum Medical
Integrations
Compare against the rest of RCM Automation Platforms
Deciding between these two?
First Pass tracks RCM Automation Platforms every week: funding, launches, and what changed since this page was written.